Skip to main content
SpringerLink
Log in

Creatine kinase, cell membrane and Duchenne muscular dystrophy

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

In 1958 Professor Setsuro Ebashi found that serum creatine kinase activity is increased in patients suffering from various muscular dystrophies, especially Duchenne muscular dystrophy (DMD). He and others proposed that creatine kinase passes through the cell membrane as it is released from DMD muscle fibers.

Since then, it has been found that dystrophin and dystrophin-associated proteins are connected to several other components, including the basal lamina and subsarcolemmal cytoskeletal networks on the cell membrane, while dystrophin anchors these dystrophin-associated proteins to the actin filaments inside the muscle cell. In DMD muscle, dystrophin has been found to be absent and dystroglycans and sarcoglycans decreased. However, how creatine kinase molecules can pass through the DMD muscle cell membrane still remains unanswered.

On the basis of recent findings on the structure of the protein layers which sandwich the lipid bilayer of muscle cell membranes, this essay stresses the importance of these lipid bilayers in protecting creatine kinase release from protoplasma in normal muscle. It further indicates the possibility that the absence of dystrophin in DMD muscle during muscle contraction may result in temporal damage to the lipid bilayer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener C, Kunkel LM: Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50: 509–517, 1987

    Google Scholar 

  2. Hoffman EP, Brown RH Jr, Kunkel LM: Dystrophin: The protein product of the Duchenne muscular dystrophy locus. Cell 51: 919–928, 1987

    Google Scholar 

  3. Koenig M, Monaco AP, Kunkel LM: The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell 53: 219–228, 1988

    Google Scholar 

  4. Hoffman EP, Kunkel LM: Dystrophin abnormalities in Duchenne/Becker muscular dystrophy. Neuron 2: 1019–1029, 1989

    Google Scholar 

  5. Arahata K, Ishiura S, Ishiguro T, Tsukahara T, Suhara Y, Eguchi C, Ishihara T, Nonaka I, Ozawa E, Sugita H: Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide. Nature 333: 861–863, 1988

    Google Scholar 

  6. Watkins SC, Hoffman EP, Slayter HS, Kunkel LM: Immunoelectron microscopic localization of dystrophin in myofibres. Nature 333: 863–866, 1988

    Google Scholar 

  7. Hoffman EP, Fischbek KH, Brown RH, Johnson M, Medori R, Loike JD, Harris JB, Waterston R, Brooke M, Specht L, Kupsky W, Chamberlain J, Caskey T, Shapiro F, Kunkel LM: Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. New Engl J Med 318: 1363–1368, 1988

    Google Scholar 

  8. Arahata K, Hoffman EP, Kunkel LM, Ishiura S, Tsukahara T, Ishihara T, Sunohara N, Nonaka I, Ozawa E, Sugita H: Dystrophin diagnosis: Comparison of dystrophin abnormalities by immunofluorescence and immunoblot analyses. Proc Natl Acad Sci USA 86: 7154–7158, 1989

    Google Scholar 

  9. Emery AEH, Emery MLH: The History of a Genetic Disease Duchenne Muscular Dystrophy or Meryon's Disease. The Royal Society of Medicine Press Limited, New York, 1995

    Google Scholar 

  10. Ebashi S, Toyokura Y, Momoi H, Sugita H: High creatine phosphokinase activity of sera of progressive muscular dystrophy. J Biochem 46: 103–104, 1959

    Google Scholar 

  11. Okinaka S, Sugita H, Momoi H, Toyokura Y, Kumagai H, Ebashi S, Fujie Y: Serum creatine phosphokinase and aldolase activity in neuromuscular disorders. Transact Amer Neurol Assoc 8462–64, 1959

    Google Scholar 

  12. Dreyfus J-C, Schapira G, Démos J: Etude de la créatine-kinase sérique chez les myopathes et leurs familles. Revue Française Etude Clinique et Biologique 5: 384–386, 1960

    Google Scholar 

  13. Engel AG, Yamamoto M, Fischbeck KH: Dystrophinopathies. In: A.G. Engel, C. Franzini-Armstrong (eds). Myology. McGraw-Hill Inc, New York, 1994, pp 1133–1187

    Google Scholar 

  14. Sugita H, Tyler FH: Pathogenesis of muscular dystrophy. Trans Assoc Amer Physicians 76: 231–243, 1963

    Google Scholar 

  15. Goto I, Nagamine M, Kathuki S: Creatine phosphokinase isozymes in-muscle. Arch Neurol 20: 422–429, 1969

    Google Scholar 

  16. Somer H, Donner M, Murros J, Konttinen A: A serum isozyme study in muscular dystrophy. Arch Neurol 29: 343–345, 1973

    Google Scholar 

  17. Takahashi K, Shutta K, Matsuo B, Takai T, Takao H, Imura H: Serum creatine kinase isoenzymes in Duchenne muscular dystrophy. Clinica Chimica Acta 75: 435–442, 1977

    Google Scholar 

  18. Rowland LP: The membrane theory of Duchenne dystrophy: Where is it? Ital J Neurol Sci 3(suppl): 13–28, 1984

    Google Scholar 

  19. Tinsley JM, Blake DJ, Zuellig RA, Davies KE: Increasing complexity of the dystrophin-associated protein complex. Proc Natl Acad Sci USA 91: 8307–8313, 1994

    Google Scholar 

  20. Ozawa E, Yoshida M, Suzuki A, Mizuno Y, Hagiwara Y, Noguchi S: Dystrophin-associated proteins in muscular dystrophy. Hum Mol Genet 4: 1711–1716, 1995

    Google Scholar 

  21. Campbell KP: Three muscular dystrophies: Loss of cytoskeletonextracellular matrix linkage. Cell 80: 675–679, 1995

    Google Scholar 

  22. Fawcett DW: A Textbook of Histology. Chapman & Hall, New York, 1994, pp 260–308

    Google Scholar 

  23. Zubrzycka-Gaarn EE, Bulman DE, Karpati G, Bughes AHM, Belfall B, Klamut HJ, Talbot J, Hodges RS, Ray PN, Worton RG: The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature 333: 466–469, 1988

    Google Scholar 

  24. Bonilla E, Samitt CE, Miranda AF, Hays AP, Salviati G, DiMauro S, Kunkel LM, Hoffman EP, Rowland LP: Duchenne muscular dystrophy: Deficiency of dystrophin at the muscle cell surface. Cell 54: 447–452, 1988

    Google Scholar 

  25. Cullen MJ, Watkins SC: Ultrastructure of muscular dystrophy: New Aspects. Micron 24: 287–307, 1993

    Google Scholar 

  26. Ervasti JM, Campbell KP: Membrane organization of the dystrophinglycoprotein complex. Cell 66: 1121–1131, 1991

    Google Scholar 

  27. Ervasti JM, Ohlendieck, K, Kahl SD, Gaver MG, Campbell KP: Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 345: 315–319, 1990

    Google Scholar 

  28. Yoshida M, Ozawa E: Glycoprotein complex anchoring dystrophin to sarcolemma. J Biochem 108: 748–752, 1990

    Google Scholar 

  29. Nigro V, Piluso G, Belsito A, Politano J, Puca AA, Papparella S, Rossi E, Viglietto G, Esposito MG, Abbondanza C, Medici N, Molinari AM, Nigro G, Puca GA: Identification of a novel sarcoglycan gene at 5q33 encoding a sarcolemmal 35 kDa glycoprotein. Hum Mol Genet 5: 1179–1186, 1996

    Google Scholar 

  30. Jung D, Duclos F, Apostol B, Straub V, Lee JC, Allamand V, Venzke, DP, Sunada Y, Moomaw CR, Leveille CJ, Slaughter CA, Crawford TO, McPherson JD, Campbell KP: Characterization of δ-sarcoglycan, a novel component of the oligomeric sarcoglycan complex involved in limb-girdle muscular dystrophy. J Biol Chem 271: 32321–32329, 1996

    Google Scholar 

  31. Yoshida M, Noguchi S, Wakabayashi E, Piluso G, Belsito A, Nigro V, Ozawa E: The fourth component of the sarcoglycan complex. FEBS Lett 403: 143–148, 1997

    Google Scholar 

  32. Yamamoto H, Hagiwara Y, Mizuno Y, Yoshida M, Ozawa E: Heterogeneity of dystrophin-associated proteins. J Biochem 114: 132–139, 1993

    Google Scholar 

  33. Yoshida M, Suzuki A, Yamamoto H, Noguchi S, Mizurto Y, Ozawa E: Dissociation of the complex of dystrophin and its associated proteins into several unique groups by n-octyl β-D-glucoside. Eur J Biochem 222: 1055–1061, 1994

    Google Scholar 

  34. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP: Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355: 696–702, 1992

    Google Scholar 

  35. Roberds SL, Leturcq F, Allamand V, Piccolo F, Jeanpierr M, Anderson RD, Lim LE, Lee JC, Tomé FMS, Romero NB, Fardeau M, Beckmann JS, Kaplan J-Q Campbell KP: Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy. Cell 78: 625–633, 1994

    Google Scholar 

  36. McNally EM, Yoshida M, Mizurto Y, Ozawa E, Kunkel LM: Human adhalin is alternatively spliced and the gene is located on chromosome 17q21. Proc Natl Acad Sci USA 91: 9690–9694, 1994

    Google Scholar 

  37. Lim LE, Duclos F, Broux O, Bourg N, Sunada Y, Allamand V, Meyer J, Richard I, Moomaw C, Slaughter C, Tomé FMS, Fardeau M, Jackson CE, Beckmann JS, Campbell KP: β-sarcoglycan: Characterization and role in limb-girdle muscular dystrophy linked to 4q12. Nature Genet 11: 257–265, 1995

    Google Scholar 

  38. Bönnemann CG, Modi R, Noguchi S, Mizuno Y, Yoshida M, Gussoni E, McNally EM, Duggan DJ, Angelini C, Hoffman EP, Ozawa E, Kunkel LM: β-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nature Genet ll: 266–273, 1995

    Google Scholar 

  39. Noguchi S, McNally EM, Ben Othmane K, Hagiwara Y, Mizuno Y, Yoshida M, Yamamoto H, Bönnermann CG, Gussoni E, Denton PH, Kyriakides T, Middleton L, Hentati F, Ben Hamida M, Nonaka I, Vance JM, Kunkel LM, Ozawa E: Mutations in the dystrophin-associated protein γ-sarcoglycan in chromosome 13 muscular dystrophy. Science 270: 819–822, 1995

    Google Scholar 

  40. Ozawa E, Noguchi S, Mizuno Y, Hagiwara Y, Yoshida M: From dystrophinopathy to sarcoglycanopathy. Evolution of a concept of muscular dystrophy. Muscle Nerve 21: 421–438, 1998

    Google Scholar 

  41. Mizuno Y, Yoshida M, Yamamoto H, Hirai S, Ozawa E: Distribution of dystrophin isoforms and dystrophin-associated proteins 43DAG (A3a) and 50DAG (A2) in various monkey tissues. J Biochem 114: 936–941, 1993

    Google Scholar 

  42. Yamamoto H, Mizuno Y, Hayashi K, Nonaka I, Yoshida M, Ozawa E: Expression of dystrophin-associated protein 35DAG (A4) and 50DAG (A2) is confined to striated muscles. J Biochem 115: 162–167, 1994

    Google Scholar 

  43. Mizuno Y, Noguchi S, Yamamoto H, Yoshida M, Suzuki A, Hagiwara Y, Hayashi, YK, Arahata K, Nonaka I, Hirai S, Ozawa E: Selective defect of sarcoglycan complex in severe childhood autosomal recessive muscular dystrophy muscle. Biochem Biophys Res Comm 203: 979–983, 1994

    Google Scholar 

  44. Adams ME, Butler MH, Dwyer TM, Peters MF, Mumane AA, Froehner SC: Two forms of mouse syntrophin, a 58 kD dystrophin-associated protein, differ in primary structure and tissue distribution. Neuron 11: 531–540, 1993

    Google Scholar 

  45. Peters MF, Kramarcy, NR, Sealock R, Froehner SC: β2-syntrophin: Localization at the neuromuscular junction in skeletal muscle. NeuroReport 5: 1577–1580, 1994

    Google Scholar 

  46. Ahn AH, Yoshida M, Anderson MS, Feener CA, Selig S, Hagiwara Y, Ozawa E, Kunkel LM: Cloning of human basic Al, a distinct 59-kDa dystrophin-associated protein encoded on chromosome 8q23–24. Proc Natl Acad Sci USA 91: 4446–4450, 1994

    Google Scholar 

  47. Adams ME, Dwyer TM, Dowler LL, White RA, Froehner SC: Mouse α1-and β2-syntrophin gene structure, chromosome localization, and homology with a discs large domain. J Biol Chem 270: 25859–25865, 1995

    Google Scholar 

  48. Yang B, Ibraghimov-Beskrovnaya O, Moomaw CR, Slaughter CA, Campbell KP: Heterogeneity of the 59-kDa dystrophin-associated protein revealed by cDNA cloning and expression. J Biol Chem 269: 6040–6044, 1994

    Google Scholar 

  49. Ahn AH, Freener CA, Gussoni E, Yoshida M, Ozawa E, Kunkel LM: The three human syntrophin genes are expressed in diverse tissues, have distinct chromosomal locations, and each bind to dystrophin and its relatives. J Biol Chem 271: 2724–2730, 1996

    Google Scholar 

  50. Carr C, Fischbach GD, Cohen JB: A novel 87,000-Mr protein associated with acetylcholine receptors in Torpedo electric organ and vertebrate skeletal muscle. J Cell Biol 109: 1753–1764, 1989

    Google Scholar 

  51. Wagner KR, Cohen JB, Huganir RL: The 87K postsynaptic membrane protein from Torpedo is a protein-tyrosine kinase substrate homologous to dystrophin. Neuron 10: 511–522, 1993

    Google Scholar 

  52. Yoshida M, Yamamoto H, Noguchi S, Mizuno Y, Hagiwara Y, Ozawa E: Dystrophin-associated protein A0 is a homologue of the Torpedo 87K protein. FEBS Lett 367: 311–314, 1995

    Google Scholar 

  53. Blake DJ, Nawrotzki R, Peters MF, Froehner SC, Davies KE: Isoform diversity of dystrobrevin, the murine 87-kDa postsynaptic protein. J Biol Chem 271: 7802–7810, 1996

    Google Scholar 

  54. Sadoulet-Puccio HM, Khurana TS, Cohen JB, Kunkel LM: Cloning and characterization of the human homologue of a dystrophin related phosphoprotein found at the Torpedo electric organ post-synaptic membrane. Hum Mol Genet 5: 489–496, 1996

    Google Scholar 

  55. Suzuki A, Yoshida M, Ozawa E: Mammalian α1-and β1-syntrophin bind to the alternative splice-prone region of the dystrophin COOH terminus. J Cell Biol 128: 373–381, 1995

    Google Scholar 

  56. Ahn AH, Kunkel LM: Syntrophin binds to an alternatively spliced exon of dystrophin. J Cell Biol 128: 363–371, 1995

    Google Scholar 

  57. Yang B, Jung D, Rafael JA, Chamberlain JS, Campbell KP: Identification of α-syntrophin binding to syntrophin triplet, dystrophin, and utrophin. J Biol Chem 270: 4975–4978, 1995

    Google Scholar 

  58. Castelló A, Brochériou V, Chafey P, Kahn A, Gilgenkrantz H: Characterization of the dystrophin-syntrophin interaction using the two-hybrid system in yeast. FEBS Lett 383: 124–128, 1996

    Google Scholar 

  59. Ervasti JM, Kahl SD, Campbell KP: Purification of dystrophin from skeletal muscle. J Biol Chem 266: 9161–9165, 1991

    Google Scholar 

  60. Ohlendieck K, Ervasti JM, Snook JB, Campbell KP: Dystrophinglycoprotein complex is highly enriched in isolated skeletal muscle sarcolemma. J Cell Biol 112: 135–148, 1991

    Google Scholar 

  61. Suzuki A, Yoshida M, Yamamoto H, Ozawa E: Glycoprotein-binding site of dystrophin is confined to the cysteine-rich domain and the first half of the carboxy-terminal domain. FEBS Lett 308: 154–160, 1992

    Google Scholar 

  62. Beggs AH, Hoffman EP, Snyder JR, Arahata K, Specht L, Shapiro F, Angelini C, Sugita H, Kunkel LM: Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies. Am J Hum Genet 49: 54–67, 1991

    Google Scholar 

  63. Monaco AP, Bertelson CJ, Liechti-Gallati S, Moser H, Kunkel LM: An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics 2: 90–95, 1988

    Google Scholar 

  64. Wapenaar, MC, Kievits T, Hart KA, Abbs S, Blonden LAJ, den Dunne JT, Grootscholten PM, Bakker E, Verellen-Dumoulin Ch, Bobrow M, van Ommen GJB, Pearson PL: A deletion hot spot in the Duchenne muscular dystrophy gene. Genomics 2: 101–108, 1988

    Google Scholar 

  65. Suzuki A, Yoshida M, Hayashi K, Mizuno Y, Hagiwara Y, Ozawa E: Molecular organization at the glycoprotein-complex-binding site of dystrophin. Three dystrophin-associated proteins bind directly to the carboxy-terminal portion of dystrophin. Eur J Biochem 220: 283–292, 1994

    Google Scholar 

  66. Jung D, Yang B, Meyer J, Chamberlain JS, Campbell KP: Identification and characterization of the dystrophin anchoring site on β-dystroglycan. J Biol Chem 270: 27305–27310, 1995

    Google Scholar 

  67. Leivo I, Engvall E: Merosin, a protein specific for basement membranes of Schwann cells, striated muscle, and trophoblast, is expressed late in nerve and muscle development. Proc Natl Acad Sci USA 85: 1544–1548, 1988

    Google Scholar 

  68. Vuolteenaho R, Nissinen M, Sainio K, Byers M, Eddy R, Hirvonen H, Show, T B, Sariola H, Engvall E, Tryggvason K: Human laminin M chain (Merosin): Complete primary structure, chromosomal assignment, and expression of the M and A chain in human fetal tissues. J Cell Biol 124: 381–394, 1994

    Google Scholar 

  69. Iwata Y, Nakamura H, Fujiwara K, Shigekawa M: Altered membranedystrophin association in the cardiomyopathic hamster heart muscle. Biochem Biophys Res Commun 190: 589–595, 1993

    Google Scholar 

  70. Mizuno Y, Noguchi S, Yamamoto H, Yoshida M, Nonaka I, Hirai S, Ozawa E: Sarcoglycan complex is selectively lost in dystrophic hamster muscle. Am J Pathol 146: 530–536, 1995

    Google Scholar 

  71. Osari S, Kobayashi O, Yamashita Y, Matsuish T, Goto M, Yanabe Y, Migita T, Nonaka I: Basement membrane abnormality in merosinnegative congenital muscular dystrophy. Acta Neuropathol 91: 332–336, 1996

    Google Scholar 

  72. Tomé FMS, Evangelista T, Leclerc A, Sunada Y, Manole E, Estornet B, Barois A, Campbell KP: Congenital muscular dystrophy with merosin deficiency. C R Acad Sci III 317: 351–357, 1994

    Google Scholar 

  73. Hillaire D, Leclerc A, Faure S, Topaloglu H, Chiannilulchai N, Guicheney P, Grinas L, Legos P, Phipot J, Evangelista T, Routon MC, Mayer M, Pellissier JF, Estournet B, Barois A, Hentati F, Feingold N, Beckmann JS, Dubowitz V, Tomé FMS, Fardeau M: Localization of merosin-negative congenital muscular dystrophy to chromosome 6q2 by homozygosity mapping. Hum Mol Genet 3: 1657–1661, 1994

    Google Scholar 

  74. Yoshida M, Mizuno Y, Nonaka I, Ozawa E: A dystrophin-associated glycoprotein, A3a (one of 43DAG doublets), is retained in Duchenne muscular dystrophy muscle. J Biochem 114: 634–639, 1993

    Google Scholar 

  75. Love DR, Hill DF, Dickson G, Spurr NK, Byth BC, Varsden RF, Walsh FS, Edwards YH, Davies KE: An autosomal transcript in skeletal muscle with homology to dystrophin. Nature 339: 55058, 1989

    Google Scholar 

  76. Tanaka H, Ishiguro T, Eguchi C, Saito K, Ozawa E: Expression of a dystrophin-related protein associated with the skeletal muscle cell membrane. Histochemistry 96: 1–5, 1991

    Google Scholar 

  77. Mizuno Y, Nonaka I, Hirai S, Ozawa E: Reciprocal expression of dystrophin and utrophin in muscles of Duchenne muscular dystrophy patients, female DMD-carriers and control subjects. J Neurol Sci 119: 43–52, 1993

    Google Scholar 

  78. Mizuno Y, Yoshida M, Nonaka I, Hirai S, Ozawa E: Expression of utrophin (dystrophin-related protein) and dystrophin-associated glycoproteins in muscles from patients with Duchenne muscular dystrophy. Muscle Nerve 17: 206–216, 1994

    Google Scholar 

  79. thi Man N, Ellis JM, Love DR, Davies KE, Gatter KC, Dickson G, Morris GE: Localization of the DMDL gene-encoded dystrophinrelated protein using a panel of nineteen monoclonal antibodies: Presence at neuromuscular junctions, in the sarcolemma of dystrophic skeletal muscle, in vascular and other smooth muscles, and in proliferating brain cell lines. J Cell Biol 115: 1695–1700, 1991

    Google Scholar 

  80. Matsumura K, Ervasti JM, Ohlendieck, K, Kahl SD, Cambpell KP: Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle. Nature 360: 588–591, 1992

    Google Scholar 

  81. Tinsley, JM, Blake DJ, Roche A, Fairbrother U, Riss J, Byth BC, Knight AE, Kendrick-Jones J, Suthers GK, Love DR, Edwards YH, Davies KE: Primary structure of dystrophin-related protein. Nature 360: 591–593, 1992

    Google Scholar 

  82. Love DR, Morris GE, Ellis JM, Fairbrother U, Marsden RF, Bloomfield JF, Edwards YH, Slater CP, Parry DJ, Davies KE: Tissue distribution of the dystrophin-related gene product and expression in the mdx and dy mouse. Proc Natl Acad Sci USA 88: 3243–3247, 1991

    Google Scholar 

  83. Bulfield G, Siller WG, Wight PAL, Moore KJ: X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA 81: 1189–1192, 1984

    Google Scholar 

  84. Sicinski P, Geng Y, Ryder-Cook AS, Barnard EA, Darlison MG, Barnard PJ: The molecular basis of muscular dystrophy in the mdx mouse: A point mutation. Science 244: 1578–1580, 1989

    Google Scholar 

  85. Bar S, Barnea E, Levy Z, Neuman S, Yaffe D, Nudel U: A novel product of the Duchenne muscular dystrophy gene which greatly differs from the known isoforms in its structure and tissue distribution. Biochem J 272: 557–560, 1990

    Google Scholar 

  86. Cox GA, Sunada Y, Campbell KP, Chamberlain JS: Dp71 can restore the dystrophin-associated glycoprotein complex in muscle but fails to prevent dystrophy. Nature Genet 8: 333–337, 1994

    Google Scholar 

  87. Greenberg DS, Sunada Y, Campbell KP, Yaffe D, Nudel U: Exogenous Dp71 restores the levels of dystrophin-associated proteins but does not alleviate muscle damage in mdx mice. Nature Genet 8: 340–344, 1994

    Google Scholar 

  88. Cox GA, Cole NM, Matsumura K, Phelps SF, Hauschka SD, Campbell KP, Faulkner JA, Chamberlain JS: Overexpression of dystrophin in transgenic mdx mice eliminated dystrophic symptoms without toxicity. Nature 364: 725–729, 1993

    Google Scholar 

  89. Tinsley JM, Potter AC, Phelps SR, Fisher R, Tricket JI, Davies KE: Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature 384: 349–353, 1996

    Google Scholar 

  90. Brenman JE, Chao DS, Xia H, Aldape K, Bredt DS: Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 82: 743–752, 1995

    Google Scholar 

  91. Belkin AM, Burridge K: Expression and localization of the phosphoglucomutase-related cytoskeletal protein, aciculin, in skeletal muscle. J Cell Sci 107: 1993–2003, 1994

    Google Scholar 

  92. Belkin AM, Burridge K: Localization of utrophin and aciculin at sites of cell-matrix and cell-cell adhesion in cultured cells. Esp Cell Res 221: 132–140, 1995

    Google Scholar 

  93. Moiseeva EP, Belkin AM, Spurr NK, Koteliansky VE, Critchley DR: A novel dystrophin/utrophin-associated protein is an enzymatically inactive member of the phosphoglucomutase superfamily. Eur J Biochem 235: 103–113, 1996

    Google Scholar 

  94. Yang B, Jung D, Motto D, Meyer J, Koretzky G, Campbell KP: SH3 domain-mediated interaction of dystroglycan and Grb2 J Biol Chem 270: 11711–11714, 1995

    Google Scholar 

  95. Song KS, Li S, Okainoto T, Quilliam LA, Sargiacomo M, Lisanti MP: Copurification and direct interaction of Ras with Caveolin, an integral membrane protein of caveolae microdomains. J Biol Chem 271: 9690–9697, 1996

    Google Scholar 

  96. Song KS, Scherer PE, Tang Z, Okamoto T, Li S, Chafel M, Chu C, Kohtz DS, Lisanti MP: Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. J Biol Chem 271: 15160–15165, 1996

    Google Scholar 

  97. Ozawa E. Muscular Dystrophy (in Japanese). Japanese Muscular Dystrophy Association, 1997

Download references

Author information

Authors and Affiliations

  1. National Institute of Neuroscience, NCNP, 4-1-1 Ogawahigashi-cho Kodaira, Tokyo, Japan

    Eijiro Ozawa, Yasuko Hagiwara & Mikiharu Yoshida

Authors
  1. Eijiro Ozawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yasuko Hagiwara
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mikiharu Yoshida
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ozawa, E., Hagiwara, Y. & Yoshida, M. Creatine kinase, cell membrane and Duchenne muscular dystrophy. Mol Cell Biochem 190, 143–151 (1999). https://doi.org/10.1023/A:1006974613418

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006974613418

Search

Navigation